Intravenous erythromycin facilitates bedside placement of postpyloric feeding tubes in critically ill adults: A double-blind, randomized, placebo-controlled study

被引:36
|
作者
Griffith, DP
McNally, AT
Battey, CH
Forte, SS
Cacciatore, AM
Szeszycki, EE
Bergman, GF
Furr, CE
Murphy, FB
Galloway, JR
Ziegler, TR
机构
[1] Emory Univ Hosp, Gen Clin Res Ctr, Dept Med, Div Endocrinol & Metab,Nutr & Metab Support Serv, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA
[3] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA
[4] Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30322 USA
关键词
erythromycin; enteral feeding; nutrition; critical illness;
D O I
10.1097/00003246-200301000-00006
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective., To evaluate the efficacy of intravenous erythromycin as a method to facilitate feeding tube placement into the small intestine in critically ill patients. Design: Double blind, randomized, controlled trial. Setting: Medical and surgical intensive care units in an academic medical center. Patients: Prospective cohort of 36 consecutive adults requiring intensive care unit care and enteral tube feeding for nutritional support. Intervention: Infusion of a single dose of intravenous erythromycin (500 mg) or saline before placement of 10-Fr feeding tubes using a standardized active bedside protocol. Measurements and Main Results: We determined the success rate of feeding tube placement into or beyond the second portion of the duodenum and the time required for this procedure by experienced nurses. The feeding tube was considered to be postpyloric when the tip was in the second portion of the duodenum or beyond. The predictive value of a serial step-up in gastrointestinal aspirate pH from less than or equal to5.0 to less than or equal to6.0 was also determined. Use of intravenous erythromycin significantly improved the rate of feeding tube placement into the duodenum or jejunum (erythromycin group, 13 of 14 patients or 93% vs. the control group, 12 of 22 patients or 55%; p < .03). Erythromycin administration also significantly decreased the procedure time from 25 +/- 3 to 15 +/- 2 mins (p < .04). Feeding tube placement into either duodenum or jejunum was confirmed in all 18 patients with a pH step-up from less than or equal to55.0 to greater than or equal to6.0. Conclusion: A single bolus dose of intravenous erythromycin facilitates active bedside placement of postpyloric feeding tubes in critically ill adult patients.
引用
收藏
页码:39 / 44
页数:6
相关论文
共 50 条
  • [1] Efficacy of erythromycin for postpyloric placement of feeding tubes in critically ill children: A randomized, double-blind, placebo controlled study
    Gharpure, V
    Meert, KL
    Sarnaik, AP
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2001, 25 (03) : 160 - 165
  • [2] Intravenous Metoclopramide to Improve the Success Rate of Blind Bedside Post-pyloric Placement of Feeding Tube in Critically Ill Children: A Randomized, Double-Blind, Placebo-Controlled Study
    Ketsuwan, Sirima
    Tanpowpong, Pornthep
    Ruangwattanapaisarn, Nichanan
    Phaopant, Supatra
    Suppalarkbunlue, Nattanicha
    Kooanantkul, Chula
    Anantasit, Nattachai
    Vaewpanich, Jarin
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [3] Erythromycin facilitates postpyloric placement of nasoduodenal feeding tubes in intensive care unit patients: Randomized, double-blinded, placebo-controlled trial
    Kalliafas, S
    Choban, PS
    Ziegler, D
    Drago, S
    Flanobaum, L
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1996, 20 (06) : 385 - 388
  • [4] Erythromycin to Promote Bedside Placement of a Self-Propelled Nasojejunal Feeding Tube in Non-Critically Ill Patients Having Pancreatitis: A Randomized, Double-Blind, Placebo-Controlled Study
    van den Bosch, Sven
    Witteman, Ellen
    Kho, YuHan
    Tan, Adriaan C. I. T. L.
    NUTRITION IN CLINICAL PRACTICE, 2011, 26 (02) : 181 - 185
  • [5] EFFECT OF ERYTHROMYCIN ON GASTRIC-MOTILITY IN MECHANICALLY VENTILATED CRITICALLY ILL PATIENTS - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    DIVE, A
    MIESSE, C
    GALANTI, L
    JAMART, J
    EVRARD, P
    GONZALEZ, M
    INSTALLE, E
    CRITICAL CARE MEDICINE, 1995, 23 (08) : 1356 - 1362
  • [6] Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled study
    Alberda, C
    Gramlich, L
    Field, C
    McCargar, L
    Meddings, J
    Madsen, K
    GASTROENTEROLOGY, 2005, 128 (04) : A281 - A282
  • [7] Prevention of Nosocomial Infections in Critically Ill Patients With Lactoferrin: A Randomized, Double-Blind, Placebo-Controlled Study
    Muscedere, John
    Maslove, David M.
    Boyd, J. Gordon
    O'Callaghan, Nicole
    Sibley, Stephanie
    Reynolds, Steven
    Albert, Martin
    Hall, Richard
    Jiang, Xuran
    Day, Andrew G.
    Jones, Gwyneth
    Lamontagne, Francois
    CRITICAL CARE MEDICINE, 2018, 46 (09) : 1450 - 1456
  • [8] A PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL OF ERYTHROMYCIN IN ADULTS WITH ACUTE BRONCHITIS
    DUNLAY, J
    REINHARDT, R
    ROI, LD
    JOURNAL OF FAMILY PRACTICE, 1987, 25 (02): : 137 - 141
  • [9] Microbial cell preparation in enteral feeding in critically ill patients: A randomized, double-blind, placebo-controlled clinical trial
    Malik, Ausama A.
    Rajandram, Retnagowri
    Tah, Pei Chien
    Hakumat-Rai, Vineya-Rai
    Chin, Kin-Fah
    JOURNAL OF CRITICAL CARE, 2016, 32 : 182 - 188
  • [10] Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial
    Alberda, Cathy
    Gramlich, Leah
    Meddings, Jon
    Field, Catherine
    McCargar, Linda
    Kutsogiannis, Demetrios
    Fedorak, Richard
    Madsen, Karen
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2007, 85 (03): : 816 - 823